Catalent, Inc. (NYSE:CTLT)’s stock price was down 8.8% on Tuesday . The company traded as low as $101.86 and last traded at $101.94. Approximately 54,452 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 1,026,055 shares. The stock had previously closed at $111.78.
Several research firms have issued reports on CTLT. JPMorgan Chase & Co. boosted their price objective on Catalent from $110.00 to $130.00 and gave the stock an “overweight” rating in a report on Friday, January 8th. Argus boosted their price target on shares of Catalent from $130.00 to $140.00 and gave the company a “buy” rating in a report on Tuesday, March 2nd. They noted that the move was a valuation call. UBS Group upped their price target on shares of Catalent from $115.00 to $135.00 and gave the company a “buy” rating in a research report on Wednesday, February 3rd. Royal Bank of Canada lifted their price objective on shares of Catalent from $125.00 to $137.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 3rd. Finally, Zacks Investment Research lowered Catalent from a “buy” rating to a “hold” rating in a report on Monday. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $125.67.
The business’s 50-day simple moving average is $108.38 and its 200-day simple moving average is $106.35. The company has a market cap of $17.65 billion, a PE ratio of 65.68, a P/E/G ratio of 2.68 and a beta of 1.50. The company has a current ratio of 2.56, a quick ratio of 2.14 and a debt-to-equity ratio of 0.97.
In other Catalent news, CFO Wetteny Joseph sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 16th. The shares were sold at an average price of $124.54, for a total value of $622,700.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO John R. Chiminski sold 42,220 shares of the stock in a transaction on Thursday, March 18th. The stock was sold at an average price of $105.16, for a total transaction of $4,439,855.20. The disclosure for this sale can be found here. Insiders have sold a total of 74,871 shares of company stock valued at $7,997,007 over the last ninety days. Company insiders own 1.00% of the company’s stock.
A number of institutional investors have recently bought and sold shares of CTLT. BlackRock Inc. lifted its position in shares of Catalent by 0.5% in the fourth quarter. BlackRock Inc. now owns 13,286,853 shares of the company’s stock worth $1,382,764,000 after buying an additional 68,225 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Catalent by 0.6% in the 4th quarter. JPMorgan Chase & Co. now owns 5,332,447 shares of the company’s stock worth $554,950,000 after purchasing an additional 31,411 shares during the last quarter. Nuveen Asset Management LLC boosted its position in Catalent by 0.8% during the fourth quarter. Nuveen Asset Management LLC now owns 1,485,969 shares of the company’s stock worth $154,645,000 after purchasing an additional 12,130 shares during the period. Norges Bank acquired a new position in Catalent during the fourth quarter valued at approximately $149,074,000. Finally, Bank of New York Mellon Corp raised its position in shares of Catalent by 5.0% in the fourth quarter. Bank of New York Mellon Corp now owns 1,362,467 shares of the company’s stock valued at $141,793,000 after purchasing an additional 64,787 shares during the period. 97.84% of the stock is currently owned by hedge funds and other institutional investors.
About Catalent (NYSE:CTLT)
Catalent, Inc, together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services.
Featured Story: What is the price-to-earnings growth (PEG) ratio?
Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.